









Markets
/
Stocks
/
nasdaq-imcc
/

IM Cannabis Corp

IMCC

1.970USD

+0.070+3.68%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

7.97MMarket Cap

LossP/E TTM



IM Cannabis Corp

1.970

+0.070+3.68%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

24 / 31

Overall Ranking

395 / 4721

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).

Growing

The company is in a growing phase, with the latest annual income totaling USD 37.57M.

Undervalued

The company’s latest PE is -3.07, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 2.47M shares, increasing 27.99% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 6.89, which is higher than the Food & Drug Retailing industry's average of 6.88. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 9.33M, representing a year-over-year decrease of 13.48%, while its net profit experienced a year-over-year decrease of 89.75%.

Score

Industry at a Glance

Previous score

6.89

Change



Financials

4.44

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.06

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.86

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 4.00, which is lower than the Food & Drug Retailing industry's average of 5.07. Its current P/E ratio is -2.97, which is -82.24% below the recent high of -0.53 and -2.05% above the recent low of -3.03.

Score

Industry at a Glance

Previous score

4.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 24/31

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

There is no earnings forecast score for this company; the Food & Drug Retailing industry's average is 7.50.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 6.43, which is lower than the Food & Drug Retailing industry's average of 7.34. Sideways: Currently, the stock price is trading between the resistance level at 2.51 and the support level at 1.38, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.43

Change

0.09

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.023

Neutral

RSI(14)

40.980

Neutral

STOCH(KDJ)(9,3,3)

59.302

Neutral

ATR(14)

0.238

Low Volatility

CCI(14)

-22.307

Neutral

Williams %R

56.637

Sell

TRIX(12,20)

-1.212

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

1.946

Buy

MA10

1.932

Buy

MA20

2.084

Sell

MA50

2.525

Sell

MA100

2.484

Sell

MA200

2.286

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-18

The company’s current institutional recognition score is 3.00, which is lower than the Food & Drug Retailing industry's average of 7.39. The latest institutional shareholding proportion is 48.05%, representing a quarter-over-quarter increase of 0.65%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Shuster (Oren)

898.35K

+45.64%

Molho (Ran)

705.67K

Gabay (Rafael)

518.52K

+33.06%

Lustig (Marc)

155.11K

AdvisorShares Investments, LLC

104.08K

Arbel (Shmulik)

54.86K

BMO Nesbitt Burns Inc.

12.48K

-0.84%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 3.08, which is lower than the Food & Drug Retailing industry's average of 4.68. The company's beta value is 2.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.